C116H156F12N24O9S — CID 159224604
4-[[4-[[(1S,2S)-2-(cyclopropanecarbonylamino)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;4-[[4-[[(1S,2S)-2-(methanesulfonamido)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(2-methylpropanoylamino)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(propanoylamino)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide (PubChem CID 159224604) has the molecular formula C116H156F12N24O9S and a molecular weight of 2290.73 g/mol. Its IUPAC name is 4-[[4-[[(1S,2S)-2-(cyclopropanecarbonylamino)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;4-[[4-[[(1S,2S)-2-(methanesulfonamido)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(2-methylpropanoylamino)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(propanoylamino)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide.
| Compound Name | 4-[[4-[[(1S,2S)-2-(cyclopropanecarbonylamino)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;4-[[4-[[(1S,2S)-2-(methanesulfonamido)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(2-methylpropanoylamino)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(propanoylamino)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide |
|---|---|
| PubChem CID | 159224604 |
| Molecular Formula | C116H156F12N24O9S |
| Molecular Weight | 2290.73 g/mol |
| Exact Mass | 2289.20 |
| IUPAC Name | 4-[[4-[[(1S,2S)-2-(cyclopropanecarbonylamino)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;4-[[4-[[(1S,2S)-2-(methanesulfonamido)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(2-methylpropanoylamino)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(propanoylamino)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide |
| SMILES | CC(C)C(=O)N[C@H]1CCCC[C@H]1Cc1nc(Nc2ccc(C(=O)N(C)C3CCN(C)CC3)cc2)ncc1C(F)(F)F.CCC(=O)N[C@H]1CCCC[C@H]1Cc1nc(Nc2ccc(C(=O)N(C)C3CCN(C)CC3)cc2)ncc1C(F)(F)F.CN1CCC(N(C)C(=O)c2ccc(Nc3ncc(C(F)(F)F)c(C[C@@H]4CCCC[C@@H]4NC(=O)C4CC4)n3)cc2)CC1.CN1CCC(N(C)C(=O)c2ccc(Nc3ncc(C(F)(F)F)c(C[C@@H]4CCCC[C@@H]4NS(C)(=O)=O)n3)cc2)CC1 |
| InChI | InChI=1S/C30H39F3N6O2.C30H41F3N6O2.C29H39F3N6O2.C27H37F3N6O3S/c1-38-15-13-23(14-16-38)39(2)28(41)20-9-11-22(12-10-20)35-29-34-18-24(30(31,32)33)26(37-29)17-21-5-3-4-6-25(21)36-27(40)19-7-8-19;1-19(2)27(40)36-25-8-6-5-7-21(25)17-26-24(30(31,32)33)18-34-29(37-26)35-22-11-9-20(10-12-22)28(41)39(4)23-13-15-38(3)16-14-23;1-4-26(39)35-24-8-6-5-7-20(24)17-25-23(29(30,31)32)18-33-28(36-25)34-21-11-9-19(10-12-21)27(40)38(3)22-13-15-37(2)16-14-22;1-35-14-12-21(13-15-35)36(2)25(37)18-8-10-20(11-9-18)32-26-31-17-22(27(28,29)30)24(33-26)16-19-6-4-5-7-23(19)34-40(3,38)39/h9-12,18-19,21,23,25H,3-8,13-17H2,1-2H3,(H,36,40)(H,34,35,37);9-12,18-19,21,23,25H,5-8,13-17H2,1-4H3,(H,36,40)(H,34,35,37);9-12,18,20,22,24H,4-8,13-17H2,1-3H3,(H,35,39)(H,33,34,36);8-11,17,19,21,23,34H,4-7,12-16H2,1-3H3,(H,31,32,33)/t2*21-,25-;20-,24-;19-,23-/m0000/s1 |
| InChIKey | KSCYVQFIUJBWSE-WJQWUGBESA-N |
| XLogP | 19.40 |
| TPSA | 378.91 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 32 |
| Heavy Atoms | 162 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2290.73 |
| LogP ≤ 5 | 19.40 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 25 |